HEADER HYDROLASE 23-JAN-04 1S6G OBSLTE 03-OCT-06 1S6G 2IEN TITLE CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT TITLE 2 NON-PEPTIDE INHIBITOR (UIC-94017) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE RETROPEPSIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HIV-1 PROTEASE; COMPND 5 SYNONYM: HIV-1 PROTEASE; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: COMPLEXED WITH UIC-94017 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: VIRUS; SOURCE 4 GENE: GAG-POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_COMMON: BACTERIA; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET11A KEYWDS HIV-1 PROTEASE; DIMER; INHIBITOR; UIC-94017; TMC114 EXPDTA X-RAY DIFFRACTION AUTHOR Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,D.MANNA,A.K.HUSSAIN, AUTHOR 2 S.LESHCHENKO,A.K.GHOSH,J.M.LOUIS,R.W.HARRISON,I.T.WEBER REVDAT 2 03-OCT-06 1S6G 1 OBSLTE REVDAT 1 08-JUN-04 1S6G 0 JRNL AUTH Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,A.K.HUSSAIN, JRNL AUTH 2 S.LESHCHENKO,A.K.GHOSH,J.M.LOUIS,R.W.HARRISON, JRNL AUTH 3 I.T.WEBER JRNL TITL HIGH RESOLUTION CRYSTAL STRUCTURES OF HIV-1 JRNL TITL 2 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR JRNL TITL 3 (UIC-94017) ACTIVE AGAINST MULTI-DRUG-RESISTANT JRNL TITL 4 CLINICAL STRAINS. JRNL REF J.MOL.BIOL. V. 338 341 2004 JRNL REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Y.KOH,H.NAKATA,K.MAAEDA,H.OGATA,G.BILCER, REMARK 1 AUTH 2 T.DEVASAMUDRAM,J.F.KINCAID,P.BOROSS,Y.F.WANG,Y.TIE, REMARK 1 AUTH 3 P.VOLARATH,L.GADDIS,R.W.HARRISON,I.T.WEBER, REMARK 1 AUTH 4 A.K.GHOSH,H.MITSUYA REMARK 1 TITL A NOVEL BIS-TETRAHYDROFURANYLURETHANE-CONTAINING REMARK 1 TITL 2 NONPEPTIDIC PROTEASE INHIBITORS (PI) UIC-94017 REMARK 1 TITL 3 (TMC114) POTENT AGAINST MULTI-PI-RESISTANT HIV IN REMARK 1 TITL 4 VITRO REMARK 1 REF ANTIMICROB. AGENTS V. 47 3123 2003 REMARK 1 REF 2 CHEMOTHER. REMARK 1 REFN ASTM AMACCQ US ISSN 7066-4804 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.134 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.173 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2831 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 56890 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3515 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 151 REMARK 3 SOLVENT ATOMS : 266 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.038 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.031 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.108 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.034 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1S6G COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.100 (2007-05-01) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PRAGUE ON 27-JAN-2004. REMARK 100 THE RCSB ID CODE IS RCSB021426. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-2002 REMARK 200 TEMPERATURE (KELVIN) : 90.0 REMARK 200 PH : 4.80 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : HKL2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56890 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 8.500 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.26800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1FG6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM CHLORIDE, SODIUM ACETATE, REMARK 280 DMSO, DIOXANE, PH 4.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 1/2-X,1/2+Y,-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.13000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.95500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.95500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 O ACY 601 O HOH 1187 0.51 REMARK 500 CH3 ACY 601 O HOH 1053 0.53 REMARK 500 O2 GOL 801 O HOH 1052 0.61 REMARK 500 NZ LYS A 70 O HOH 1142 0.64 REMARK 500 C1 GOL 802 O HOH 1034 0.67 REMARK 500 CH3 ACY 602 O HOH 1153 0.70 REMARK 500 O3 GOL 802 O HOH 1090 0.72 REMARK 500 OD2 ASP A 30 O HOH 1233 0.80 REMARK 500 OXT ACY 601 O HOH 1210 0.89 REMARK 500 O28 017 402 O HOH 1222 0.95 REMARK 500 OD1 ASP B 130 O HOH 1060 0.99 REMARK 500 OE1 GLU A 21 O HOH 1238 1.04 REMARK 500 O1 GOL 802 O HOH 1034 1.04 REMARK 500 C ACY 601 O HOH 1187 1.19 REMARK 500 C29 017 402 O HOH 1224 1.21 REMARK 500 C29 017 402 O HOH 1222 1.23 REMARK 500 C2 GOL 802 O HOH 1034 1.27 REMARK 500 O28 017 402 O HOH 1224 1.30 REMARK 500 O HOH 1081 O HOH 1243 1.33 REMARK 500 C3 GOL 802 O HOH 1090 1.36 REMARK 500 C35 017 402 O HOH 1223 1.39 REMARK 500 C ACY 601 O HOH 1210 1.39 REMARK 500 CD GLU A 21 O HOH 1238 1.45 REMARK 500 NH1 ARG A 8 O HOH 1237 1.47 REMARK 500 C1 GOL 801 O HOH 1109 1.47 REMARK 500 C3 GOL 801 O HOH 1109 1.60 REMARK 500 O1 GOL 801 O HOH 1160 1.61 REMARK 500 OD1 ASP A 30 O HOH 1231 1.63 REMARK 500 OXT ACY 602 O HOH 1063 1.66 REMARK 500 NH1 ARG B 108 O HOH 1086 1.68 REMARK 500 O3 GOL 801 O HOH 1113 1.68 REMARK 500 CG ASP B 130 O HOH 1060 1.74 REMARK 500 O ILE A 50 O HOH 1243 1.76 REMARK 500 NZ LYS B 114 O HOH 1101 1.80 REMARK 500 OXT ACY 601 O HOH 1187 1.84 REMARK 500 CZ ARG B 108 O HOH 1086 1.86 REMARK 500 O HOH 1066 O HOH 1212 1.86 REMARK 500 OE2 GLU A 21 O HOH 1238 1.88 REMARK 500 CG ASP A 30 O HOH 1231 1.90 REMARK 500 CE LYS A 70 O HOH 1142 1.90 REMARK 500 C2 GOL 801 O HOH 1109 1.92 REMARK 500 CH3 ACY 601 O HOH 1210 1.93 REMARK 500 C ACY 601 O HOH 1053 1.94 REMARK 500 C2 GOL 801 O HOH 1052 1.95 REMARK 500 CG ASP A 30 O HOH 1233 1.98 REMARK 500 CZ ARG A 8 O HOH 1237 1.99 REMARK 500 O HOH 1133 O HOH 1246 2.03 REMARK 500 O HOH 1178 O HOH 1219 2.06 REMARK 500 C27 017 402 O HOH 1222 2.08 REMARK 500 C2 GOL 802 O HOH 1090 2.13 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 50 CA - C - O ANGL. DEV. =-20.5 DEGREES REMARK 500 GLY A 51 C - N - CA ANGL. DEV. = 16.9 DEGREES REMARK 500 ASP B 130 CB - CG - OD2 ANGL. DEV. = 18.9 DEGREES REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 1178 DISTANCE = 5.36 ANGSTROMS DBREF 1S6G A 1 99 UNP P03367 POL_HV1BR 69 167 DBREF 1S6G B 101 199 UNP P03367 POL_HV1BR 69 167 SEQADV 1S6G LYS A 7 UNP P03367 GLN 75 ENGINEERED SEQADV 1S6G ILE A 33 UNP P03367 LEU 101 ENGINEERED SEQADV 1S6G ILE A 63 UNP P03367 LEU 131 ENGINEERED SEQADV 1S6G ALA A 67 UNP P03367 CYS 135 ENGINEERED SEQADV 1S6G ALA A 95 UNP P03367 CYS 163 ENGINEERED SEQADV 1S6G LYS B 107 UNP P03367 GLN 75 ENGINEERED SEQADV 1S6G ILE B 133 UNP P03367 LEU 101 ENGINEERED SEQADV 1S6G ILE B 163 UNP P03367 LEU 131 ENGINEERED SEQADV 1S6G ALA B 167 UNP P03367 CYS 135 ENGINEERED SEQADV 1S6G ALA B 195 UNP P03367 CYS 163 ENGINEERED SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE HET NA 501 1 HET CL 502 1 HET CL 503 1 HET 017 402 148 HET ACY 601 4 HET ACY 602 4 HET GOL 801 6 HET GOL 802 6 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM 017 (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3- HETNAM 2 017 [[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2- HETNAM 3 017 HYDROXYPROPYLCARBAMATE HETNAM ACY ACETIC ACID HETNAM GOL GLYCEROL HETSYN 017 TMC114; UIC-94017 FORMUL 3 NA NA 1+ FORMUL 4 CL 2(CL 1-) FORMUL 6 017 C27 H37 N3 O7 S FORMUL 7 ACY 2(C2 H4 O2) FORMUL 9 GOL 2(C3 H8 O3) FORMUL 11 HOH *246(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 186 THR B 191 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 198 SHEET 4 A 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 THR A 31 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 LYS B 143 GLY B 149 0 SHEET 2 C 8 GLY B 152 ILE B 166 -1 O GLN B 158 N LYS B 143 SHEET 3 C 8 HIS B 169 VAL B 177 -1 O HIS B 169 N ILE B 166 SHEET 4 C 8 VAL B 132 ILE B 133 1 N ILE B 133 O LEU B 176 SHEET 5 C 8 ILE B 184 ILE B 185 -1 O ILE B 184 N VAL B 132 SHEET 6 C 8 GLN B 118 LEU B 124 1 N LEU B 123 O ILE B 185 SHEET 7 C 8 LEU B 110 ILE B 115 -1 N ILE B 113 O LYS B 120 SHEET 8 C 8 GLY B 152 ILE B 166 -1 O GLU B 165 N LYS B 114 CRYST1 58.260 85.910 46.051 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017164 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011640 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021715 0.00000